Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology. Entelexo Biotherapeutics is a Y Combinator company (Winter 2021). YC-listed status: Active.
- Website
- entelexo.com
- Location
- Irvine, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Entelexo — Proprietary exosome engineering platform developing multi-target therapeutics for autoimmune diseases including rheumatoid arthritis, Crohn's, and psoriasis. · Other
Links
- Y Combinator profileycombinator